- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q3 2024 · Sep 30, 2024 | $73.92M |
| Capex | Q3 2024 · Sep 30, 2023 | $45.31M |
| Long Term Debt | Q3 2024 · Sep 30, 2024 | $502.47M |
| Long Term Debt | Q3 2024 · Dec 31, 2023 | $527.12M |
| Short Term Debt | Q3 2024 · Sep 30, 2024 | $137.63M |
| Short Term Debt | Q3 2024 · Dec 31, 2023 | $42.15M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $100.85M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $125.15M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $530.42M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $528.6M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $321.66M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $233.67M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $1.01B |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $963.69M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $224.14M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $218.02M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $1.56B |
| Total Assets | Q3 2024 · Dec 31, 2023 | $1.5B |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 62.59M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 62.59M sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$21.31M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.10 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$1.51 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.10 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$1.51 |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $34.38M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $94.9M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$6.05M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$92.94M |
| Operating Income | Q3 2024 · Sep 30, 2023 | $15.72M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$14.07M |
| Revenue | Q3 2024 · Sep 30, 2023 | $271.82M |
| Revenue | Q3 2024 · Sep 30, 2023 | $572.92M |